MedPath

Ferumoxytol

These highlights do not include all the information needed to use FERUMOXYTOL INJECTION safely and effectively. See full prescribing information for FERUMOXYTOL INJECTION. FERUMOXYTOL injection, for intravenous use Initial U.S. Approval: 2009

Approved
Approval ID

cf94c7fc-13a0-4ac9-bb85-9c38aa704d35

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 27, 2022

Manufacturers
FDA

Sandoz Inc

DUNS: 005387188

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ferumoxytol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0781-3154
Application NumberANDA206604
Product Classification
M
Marketing Category
C73584
G
Generic Name
ferumoxytol
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 22, 2020
FDA Product Classification

INGREDIENTS (2)

MANNITOLInactive
Quantity: 748 mg in 17 mL
Code: 3OWL53L36A
Classification: IACT
FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITEActive
Quantity: 510 mg in 17 mL
Code: CLH5FT6412
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ferumoxytol - FDA Drug Approval Details